Sciformix Corporation and Cambridge Semantics Partner to Create Enhanced Pharmacovigilance Automation and Technology Platform for Life Science Companies

Share Article

New partnership enables safety organizations to greatly reduce timelines, increase quality, and glean enhanced insights for effective scientific data management

Cambridge Semantics Logo

Sciformix Corporation and Cambridge Semantics partner to impraove pharmacovigilance processes, and to transform and help interpret big data for the life science industry.

Sciformix Corporation, a leading scientific knowledge-based organization, and Cambridge Semantics, The Smart Data Company®, today announced a partnership to launch a semantic technology layer, specifically tailored to pharmacovigilance processes that will transform and help interpret big data for the life science industry. This technology platform will allow Sciformix to further enhance its targeted pharmacovigilance automation suite for its clients.

The solution combines Sciformix’s domain expertise in pharmacovigilance with Cambridge Semantics’ Anzo Smart Data Lake® to build safety-specific ontologies onto the platform, enabling life science companies to transform existing legacy data models into self-service analytics to maximize the value of their data. The semantic layer of technology on the data lake is able to process and make sense of vast quantities of structured and unstructured data to allow users to see patterns, signals and extract analytics from the information. The platform can help operationalize machine learning and artificial intelligence to allow it to improve over time and further automate practices, including case processing and medical review, enabling users to have fewer touch points with their data.

Sciformix President and CEO Manish Soman commented, “Sciformix is excited to announce this collaboration, which will enhance pharmacovigilance processes in the industry through a new, comprehensive end-to-end solution. We chose to work with the Cambridge Semantics open platform as it is scalable, capable of handling large quantities of data and able to provide advanced analytics. As the scientific work carried out by Sciformix and its clients is very data intensive, this was essential.”

He added, “The platform will enable us to provide a pharmacovigilance solution that will go beyond automating rule-based activities. It will leverage cognitive computing and artificial intelligence technologies based on machine learning and natural language processing (NLP) to build a comprehensive automation platform. This will improve the predictability of regulatory compliance and quality standards, and also allow teams to use the power of analytics to focus on complex, high-level downstream scientific work involving evaluation and interpretation activities.”

Alok Prasad, President of Cambridge Semantics said, “We are pleased to partner with Sciformix and extend their industry leading safety and pharmacovigilance expertise with our powerful Anzo Smart Data Lake product. Our semantically driven, big data graph platform will provide Sciformix with the unprecedented automation capabilities needed to process and understand vast amounts of medical information, enabling better patient safety for their clients.”

Both companies will be discussing this powerful solution set at World Drug Safety Congress, 2018 April 10-11th at the Hilton Philadelphia City Avenue at Booth 11. In addition Fran Bates, Vice President of Technology Services at Sciformix and Jim LaPointe, Managing Director at Cambridge Semantics, will be presenting together on “PV Automation Journey: Past, Present and Future” at 3:10 PM EST on April 10th.

Sciformix, headquartered in the United States with operations in Europe, India, and Philippines, partners with life science organizations to provide a full range of services, from study design to post-marketing surveillance. Areas of specialization include safety and risk management, clinical development, real world evidence and market research, scientific writing, regulatory affairs, and technology services.

To learn more about Sciformix, visit , email us at, or call us at +1.877.576.5005.

For further press information please contact: Scott Girling-Heathcote, The Scott Partnership: + 44 1477 539539 mail to or Susan Najjar, Director of Marketing, Sciformix Corporation: + 1 617-264-0339 mail to
Media contact for Cambridge Semantics, Lora Wilson, Global Results Communications,, +1 (949) 608-0276

About Cambridge Semantics
Cambridge Semantics Inc., The Smart Data Company®, is a big data management and enterprise analytics software company that offers a universal semantic layer to connect and bring meaning to all enterprise data. Its software, the Anzo Smart Data Lake®, allows IT departments and their business users to semantically link, analyze and manage diverse data whether internal or external, structured or unstructured, with speed, at big data scales and at the fraction of the implementation costs of using traditional approaches. For more information visit

About Sciformix
Sciformix Corporation is a leading scientific knowledge-based organization that provides process, technology and consulting services to the life sciences industry. We employ best-in-class strategies, technologies and expertise that accelerates business drives higher levels of performance and fosters innovation. What differentiates Sciformix is our ability to integrate scientific and technology expertise with quality driven processes to provide value to our clients throughout the entire drug development cycle. Our areas of specialization include Safety & Risk Management, Clinical Research & Post-Approval Support Services, Regulatory Affairs & Regulatory Operations, and Technology Services. Corporate headquarters is located in Westborough, MA with operations in NA, Europe, India and the Philippines.

We create value for our clients through our singular focus on the life sciences industry, strong pharmaceutical domain competency, exceptional subject matter expertise, uncompromising focus on quality, process rigor, predictable results, and ability to scale. Our portfolio of services spans the full spectrum of product lifecycle from pre-clinical and clinical to post marketing activities to help our customers solve complex analytical challenges, improve the quality of patient healthcare and increase client productivity.

Sciformix is dedicated to providing our clients outstanding services and solutions, fuelled by an unrivalled commitment to quality. We share the same level of involvement, dedication and passion as our clients and become an integral part of their team. Our distinct combination of scientific expertise, process rigor and technology innovation delivers consistent, reliable and insightful results. Our ability to scale and grow to meet your evolving needs means we are flexible and dedicated to your success in delivering safe products with more efficiency and greater speed. We help you make the right decisions at the right time by providing Trusted Services Built on Science. For more information, please visit:

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Lora Wilson
+1 9499297234
Email >
Visit website